Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa
NCT05722184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1724
Last updated 2025-12-09
Summary
Diagnosis of bloodstream infections (BSI) is done by sampling blood in blood culture bottles that are checked for growth in the microbiology laboratory. In LRS, microbiology laboratories are however scarce, and BSI cannot be diagnosed, resulting in overuse of antibiotics which fuels AMR. For diagnosis of BSI, so-called manual blood culture (equipment-free) systems are used in LRS, with daily visual inspection for growth. Compared to automates, manual systems are less sensitive, and growth is slower; in addition, training and experience are needed before laboratory staff is competent to detect growth when inspecting the blood culture bottles.
A simplified blood culture system could enable expanded use of blood cultures in LRS and would thus improve BSI treatment. Ongoing research at the Institute of Tropical Medicine, in collaboration with Ghent University has resulted in a novel, simple, cheap, open-access and robust blood culture system, the Bactinsight blood culture system. This system consists of two modules. Firstly, a portable, battery-operated measurement device (turbidimeter), which monitors and detects bacterial growth in blood culture bottles based on the turbidity of the culture medium caused by bacterial growth. Secondly, optimized blood culture bottles have been developed. A second step in blood cultures is the identification of the causing organism. Researchers at LETI (Grenoble, France) have developed a lensfree microscope, which simplifies and expedites identification of the causative organisms, improving patient's diagnosis and more directed antibiotic treatment. The lensfree microscope is an additional module for the Bactinsight blood culture system.
In SIMBLE, the Bactinsight blood culture system will be evaluated against reference systems in two phases. During the optimization phase in Belgium, the performance of Bactinsight turbidimeter + lensfree microscope will be tested in a reference hospital laboratory. In parallel, an in vitro laboratory evaluation of the Bactinsight blood culture system (turbidimeter + blood culture bottles + lensfree microscope) will be done using spiked blood cultures. In the field-testing phase, the ease-of-use, acceptability, adoptability and performance of Bactinsight blood culture system will be evaluated in three hospitals in Benin and Burkina Faso. The blood culture bottles used for this study will be manufactured in a production facility in Benin, that will be installed at the start of the project.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
BactInsight blood culture system
A battery-operated measurement device (turbidimeter), which monitors and detects bacterial growth in blood culture bottles based on the turbidity of the culture medium caused by bacterial growth, in combination with optimized blood culture bottles.
Sponsors & Collaborators
-
Reactivos para Diagnóstico, S.L.
collaborator UNKNOWN -
University Ghent
collaborator OTHER -
Université Libre de Bruxelles
collaborator OTHER -
Commissariat A L'energie Atomique
collaborator OTHER_GOV -
Centre Hospitalier Universitaire Yalgado Ouédraogo
collaborator UNKNOWN -
Centre National Hospitalier et Universitaire de Pneumo-Phtisiologie de Cotonou
collaborator UNKNOWN -
European and Developing Countries Clinical Trials Partnership (EDCTP)
collaborator OTHER_GOV -
Institute of Tropical Medicine, Belgium
lead OTHER
Principal Investigators
-
Barbara Barbé · Instituut voor Tropische Geneeskunde
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-08
- Primary Completion
- 2025-05-08
- Completion
- 2025-09-01
Countries
- Benin
Study Locations
More Related Trials
-
PCR-Based Detection of Bacterial Agents in Platelet Concentrates and Whole Blood
NCT00482339 ·Status: UNKNOWN
-
MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial
NCT00814151 ·Status: COMPLETED
-
Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System
NCT05672875 ·Status: TERMINATED
-
Burden of Staphylococcus Lugdunensis Infections in Hospitalized Patients
NCT04318262 ·Status: UNKNOWN
-
Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity
NCT05522764 ·Status: UNKNOWN
-
NExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective Endocarditis
NCT04257292 ·Status: UNKNOWN
-
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC
NCT04235361 ·Status: UNKNOWN
-
Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives
NCT01184339 ·Status: COMPLETED
-
Application of NGS Technique in Precise Diagnosis of Infectious Diseases
NCT03232242 ·Status: UNKNOWN
-
Invasive Markers of Staphylococcus Epidermidis
NCT03374371 ·Status: COMPLETED
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
Detection of Bloodstream Pathogens in Hematological Malignancies
NCT03896880 ·Status: COMPLETED
-
MDR Bacilli Surveillance and Clinical Feature in China
NCT02140853 ·Status: UNKNOWN
-
Surveillance of AMR in DRC
NCT06821282 ·Status: RECRUITING
-
Epidemiological Study on Invasive Bacterial Diseases
NCT06322290 ·Status: RECRUITING
-
Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections
NCT01198262 ·Status: COMPLETED
-
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3
-
Biobank of Samples From Patients With Infectious Diseases
NCT06722131 ·Status: NOT_YET_RECRUITING
-
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine
NCT04328441 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections
NCT03833102 ·Status: COMPLETED
-
Multi-Drug Resistant Organism Network
NCT03646227 ·Status: COMPLETED
-
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
NCT01898208 ·Status: COMPLETED ·Phase: NA
-
BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches
NCT06187662 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
NCT06594250 ·Status: RECRUITING
-
Bacteriophage Therapy of Difficult-to-treat Infections
NCT05498363 ·Status: COMPLETED